Phase II trial of subcutaneous interferon followed by intravenous hybrid bolus/continuous infusion interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy Research Group 95-09. [electronic resource]
Producer: 20060718Description: 130-7 p. digitalISSN:- 1084-9785
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.